Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder
NCT00131339
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Panic Disorder
Interventions
BEHAVIORAL:
Cognitive behavioral therapy
DRUG:
D-cycloserine
Sponsor
Hartford Hospital